Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 3, 2022
This year's research centered on advancements in kidney transplantation and equity in patient care DaVita addresses equitable access to breakthrough trials and decentralized research by...
-
Oct 28, 2022
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2022. "The third quarter was a challenging quarter for us. Like others in the healthcare...
-
Oct 14, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time. The company plans...
-
Oct 10, 2022
Grant to enable nonprofit organizations in the Food Is Medicine Coalition to expand services for medically-tailored meals for individuals with chronic medical conditions. DENVER, Oct. 10, 2022...
-
Sep 30, 2022
Hurricane Ian made landfall in Florida on September 28, bringing severe storm conditions to a large portion of the state. The storm is now moving towards Georgia and the Carolinas, and expected to...
-
Sep 13, 2022
DaVita Inc. announced today that its Board of Directors appointed a new independent director, Adam H. Schechter, to join the Board, effective September 20, 2022. Mr. Schechter is the President,...
-
Aug 1, 2022
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2022. "We are living in a dynamic time with a sustained global pandemic, labor shortage, supply...
-
Jul 18, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time. The company plans...
-
Jun 22, 2022
DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. This call follows this week's U.S. Supreme...
-
May 26, 2022
Companies join forces to accelerate kidney care device innovation and improve patient outcomes DUBLIN and DENVER, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA)...
-
May 10, 2022
DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of the DAISY Foundation's™...
-
May 9, 2022
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare...
-
May 5, 2022
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a decrease of (10.1)% from the prior...
-
May 3, 2022
Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report. "I'm humbled...
-
Apr 21, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to...
-
Apr 7, 2022
DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of...
-
Apr 4, 2022
Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase...
-
Feb 17, 2022Research further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis...
-
Feb 16, 2022Dr. Mihran Naljayan will take the clinical leadership role for DaVita
DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical...
-
Feb 14, 2022Company helps ease financial burden for living donors, encourages other employers to follow suit
In honor of National Donor Day—and every living organ donor—DaVita announced it increased paid leave for organ donation to four consecutive weeks for benefits-eligible teammates (employees)...
-
Feb 10, 2022
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2021. "COVID continues to evolve and have a direct impact on our world, especially on...
-
Feb 1, 2022
Beginning Sunday, areas in the Southeast and along the East Coast will experience inclement winter weather, which is expected to go through Monday. Communities in northeast Georgia, the Carolinas...
-
Jan 27, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 10, 2022, at 5:00 p.m. Eastern Time. The company...
-
Jan 19, 2022Programs aim to slow the progression of kidney disease and increase access to home dialysis and kidney transplantation
DaVita Integrated Kidney Care (DaVita IKC)—along with nearly 1,000 kidney doctors, transplant providers, hospice providers and advanced care practitioners—today announced the launch of 11...
-
Jan 18, 2022Transplant software company helps DaVita bolster its presence along the kidney care journey
DaVita Inc. today announced its acquisition of transplant software company MedSleuth. Working with transplant centers across the U.S., MedSleuth aims to create greater connectivity among...